LeadIQ logo
Learn more at LeadIQ.com

Insights

Antibiotic resistance focus Tetraphase Pharmaceuticals is dedicated to fighting antibiotic resistance, a global health threat. Their focus on developing novel antibiotics to combat drug-resistant bacteria presents a prime sales opportunity for healthcare institutions seeking effective treatment solutions.

Recent acquisitions Recent acquisitions by pharmaceutical companies such as La Jolla and Melinta indicate an industry trend towards strategic partnerships and consolidation. This presents a potential sales opportunity for Tetraphase to leverage their expertise and products to attract new partners and expand their market reach.

Partnerships with industry leaders Collaborations with industry leaders like Intalere and AcelRx demonstrate Tetraphase's ability to establish beneficial partnerships. Leveraging these connections can provide a sales avenue for Tetraphase to introduce their antibiotic solutions to a wider network of healthcare providers and organizations.

Financial backing With a recent funding round of $4 million, Tetraphase Pharmaceuticals has the financial stability to support their research and development efforts. This positions them well to engage in sales discussions with potential investors or collaborators looking to invest in innovative antibiotic therapies.

Tech-savvy approach Utilizing a tech stack that includes Google Cloud, WordPress, and Modernizr showcases Tetraphase's commitment to leveraging technology for enhanced operations. This tech-savvy approach presents an opportunity for sales teams to highlight Tetraphase's innovative capabilities when engaging with tech-focused healthcare organizations.

Similar companies to Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals Tech Stack

Tetraphase Pharmaceuticals uses 8 technology products and services including SiteCatalyst, WordPress, Twitter Emoji (Twemoji), and more. Explore Tetraphase Pharmaceuticals's tech stack below.

  • SiteCatalyst
    Analytics
  • WordPress
    Content Management System
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Google Charts
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • reCAPTCHA
    Security

Media & News

Tetraphase Pharmaceuticals's Email Address Formats

Tetraphase Pharmaceuticals uses at least 1 format(s):
Tetraphase Pharmaceuticals Email FormatsExamplePercentage
FLast@tphase.comJDoe@tphase.com
92%
Last@tphase.comDoe@tphase.com
3%
LFirst@tphase.comDJohn@tphase.com
2%
First.Last@tphase.comJohn.Doe@tphase.com
3%

Frequently Asked Questions

Where is Tetraphase Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals's main headquarters is located at 480 Arsenal St Watertown, Massachusetts 02472 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Tetraphase Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Tetraphase Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tetraphase Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals is a publicly traded company; the company's stock symbol is TTPH.

What is Tetraphase Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals's official website is tphase.com and has social profiles on LinkedIn.

What is Tetraphase Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tetraphase Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of May 2022, Tetraphase Pharmaceuticals has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Vice President Operations: P. R.Vice President Of Sales And Marketing: T. O.Founder: P. H.. Explore Tetraphase Pharmaceuticals's employee directory with LeadIQ.

What industry does Tetraphase Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Tetraphase Pharmaceuticals use?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals's tech stack includes SiteCatalystWordPressTwitter Emoji (Twemoji)Font AwesomeGoogle CloudGoogle ChartsModernizrreCAPTCHA.

What is Tetraphase Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals's email format typically follows the pattern of . Find more Tetraphase Pharmaceuticals email formats with LeadIQ.

How much funding has Tetraphase Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of May 2022, Tetraphase Pharmaceuticals has raised $4M in funding. The last funding round occurred on Apr 01, 2017 for $4M.

When was Tetraphase Pharmaceuticals founded?

Minus sign iconPlus sign icon
Tetraphase Pharmaceuticals was founded in 2006.
Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals

Biotechnology ResearchMassachusetts, United States51-200 Employees

Tetraphase is fighting one of the most significant threats to humanity — antibiotic resistance — through the promise of our technology and the passion of our people. We are committed to making novel antibiotics accessible to all patients in need. 

According to The Review on Antimicrobial Resistance (May 2016), by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company. It unites us in a common goal and fuels our determination to develop new antibiotics that can overcome the challenges of drug-resistant bacteria and ensure the availability of effective treatments in the future.

By virtue of our size, novel technology, and well-defined mission targeting antibiotic resistance, Tetraphase has the focus and flexibility to explore a broad range of antibiotic solutions.

Our lead product, XERAVA, is approved for the treatment of complicated intra-abdominal infections (cIAI), find out more at XERAVA.com 

Section iconCompany Overview

Headquarters
480 Arsenal St Watertown, Massachusetts 02472 US
Phone number
Website
tphase.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TTPH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $4M

    Tetraphase Pharmaceuticals has raised a total of $4M of funding over 7 rounds. Their latest funding round was raised on Apr 01, 2017 in the amount of $4M.

Section iconFunding & Financials

  • $4M

    Tetraphase Pharmaceuticals has raised a total of $4M of funding over 7 rounds. Their latest funding round was raised on Apr 01, 2017 in the amount of $4M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.